Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 1 - 25 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species ▲ Gene ID Gene Symbol FlyGlycoDB Evidence References
DOID:0050742 nicotine dependence WB:WBGene00000054 Caenorhabditis elegans 191602 acr-15 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:17081982
DOID:162 cancer WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:21572423
DOID:162 cancer WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 mutant phenotype evidence used in manual assertion
  • PMID:21572423
DOID:3211 lysosomal storage disease WB:WBGene00021546 Caenorhabditis elegans 3565323 laat-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:22822152
DOID:14323 Marfan syndrome WB:WBGene00003482 Caenorhabditis elegans 176430 mua-3 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25917920
DOID:1064 cystinosis WB:WBGene00008052 Caenorhabditis elegans 174308 ctns-1 mutant phenotype evidence used in manual assertion
  • PMID:22822152
DOID:162 cancer WB:WBGene00006638 Caenorhabditis elegans 177890 tsp-12 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25978409
DOID:1289 neurodegenerative disease WB:WBGene00004033 Caenorhabditis elegans 181166 pkc-2 sequence orthology evidence used in manual assertion
  • PMID:28716951
DOID:14330 Parkinson's disease WB:WBGene00000898 Caenorhabditis elegans 175410 daf-2 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:24882066
DOID:9870 galactosemia WB:WBGene00008132 Caenorhabditis elegans 173171 gale-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25298520
DOID:1289 neurodegenerative disease WB:WBGene00010775 Caenorhabditis elegans 187297 poml-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:26941331
DOID:9352 type 2 diabetes mellitus WB:WBGene00003858 Caenorhabditis elegans 176000 ogt-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:16051707
  • PMID:16882729
DOID:2962 Cockayne syndrome WB:WBGene00008403 Caenorhabditis elegans 174474 csa-1 mutant phenotype evidence used in manual assertion
  • PMID:25453470
DOID:0060730 torsion dystonia 1 WB:WBGene00003870 Caenorhabditis elegans 174433 ooc-5 mutant phenotype evidence used in manual assertion
  • PMID:11714689
DOID:9281 phenylketonuria WB:WBGene00000253 Caenorhabditis elegans 171608 bli-3 mutant phenotype evidence used in manual assertion
  • PMID:18460651
DOID:10652 Alzheimer's disease WB:WBGene00003001 Caenorhabditis elegans 176282 lin-12 mutant phenotype evidence used in manual assertion
  • PMID:7566091
DOID:14503 neuronal ceroid lipofuscinosis WB:WBGene00004092 Caenorhabditis elegans 191744 ppt-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:15672447
DOID:1289 neurodegenerative disease WB:WBGene00001621 Caenorhabditis elegans 177882 glt-3 mutant phenotype evidence used in manual assertion
  • PMID:19054279
  • PMID:25422944
DOID:809 cocaine abuse WB:WBGene00003386 Caenorhabditis elegans 179269 mod-1 mutant phenotype evidence used in manual assertion
  • PMID:19536276
DOID:557 kidney disease WB:WBGene00016848 Caenorhabditis elegans 177557 klo-1 mutant phenotype evidence used in manual assertion
  • PMID:21177529
DOID:1289 neurodegenerative disease WB:WBGene00010775 Caenorhabditis elegans 187297 poml-1 mutant phenotype evidence used in manual assertion
  • PMID:26941331
DOID:1184 nephrotic syndrome WB:WBGene00006365 Caenorhabditis elegans 180555 syg-1 mutant phenotype evidence used in manual assertion
  • PMID:20233749
DOID:14330 Parkinson's disease WB:WBGene00002048 Caenorhabditis elegans 175807 ida-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25469508
DOID:65 connective tissue disease WB:WBGene00022816 Caenorhabditis elegans 176076 fbn-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25798732
DOID:12858 Huntington's disease WB:WBGene00018294 Caenorhabditis elegans 179246 atg-18 mutant phenotype evidence used in manual assertion
  • PMID:17172799

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025